Tuesday, December 12, 2017

SOCIETATEA ROMANA IMPOTRIVA EPILEPSIEI a XXIII-a Conferinta SRIE

img1CASA CESIANU - BUCURESTI

19-21 NOIEMBRIE 2015

 

SPEAKERI INVITATI: 

Meir Bialer, Israel, Chair CEA-ILAE

Walter van Emde Boas, Olanda

Olivier Delalande, Franta

Olivier Dulac, Franta

Svetlana Gataullina, Franta

Thea Gutter, Olanda

 

CUVÂNT DE BUN VENIT

Dragi colegi,

Avem onoarea și plăcerea de a vă invita în numele Comitetului de Organizare și al Comitetului Științific, să participați la cea de a XXIII-a Conferință a Societății Române Impotriva Epilepsiei (SRIE), ce va avea loc la București în perioada 19-21 noiembrie 2015, intr-o locatie inedita – Casa Cesianu.

Conferinta este deja o traditie si reuneste specialisti din toate domeniile care se ocupa de epilepsie.

În cadrul programului științific al conferinței ne-am propus anul acesta să abordăm o tema cu implicație practică în activitatea noastră zilnică, și anume: Epilepsia in diversele patologii ale copilului si adultului.

Tinerii noștri colegi, rezidenți dar și specialiștii neurologi, vor avea ocazia să discute realizări recente în diagnostic și tratament.

Așteptăm cu nerăbdare să vă revedem la conferința SRIE și vă încurajăm să participați activ prin trimiterea în termenul cerut a rezumatelor pentru prezentări orale și postere.

Nutrim speranța că prin participarea Dumneavoastră vom reuși să continuăm tradiția și să facem și din acest eveniment un succes. Societatea a functionat prin entuziasmul si dedicarea presedintelui sau, Profesor Dr. Radu Rogozea, dar provocarile viitorului necesita o munca de echipa.

Dorim sa revigoram Societatea prin primirea de noi membri, prin dezvoltarea de noi proiecte vizand atat programe de formare profesionala in diverse arii ale epileptologiei (electroencefalografie, tratament medicamentos si alternativ, femeia cu epilepsie, etc), cat si sociale cu privire la pacientul cu epilepsie si drepturile lui.

Asocierea cu organizatiile de pacienti va duce la o mai buna intelegere a tuturor problemelor de care se lovesc persoanele cu epilepsie, pentru ca impreuna sa putem gasi cele mai bune solutii de abordare si rezolvare a acestora.

ile romania banner 1

 

Vă așteptăm cu drag,

Profesor Dr. Dana Craiu Profesor Dr. Radu Rogozea

Președinte al Conferintei SRIE Președinte al SRIE

Read more: SOCIETATEA ROMANA IMPOTRIVA EPILEPSIEI a XXIII-a Conferinta SRIE

Primul Anunt - Congres SNR 2016

SOCIETATEA DE NEUROLOGIE DINROMÂNIA

FUNDATIA SOCIETATII DE NEUROLOGIE DIN ROMANIA

ŞI

UNIVERSITATEA DE MEDICINĂ ŞI FARMACIE

CAROL DAVILA

BUCUREŞTI

Organizează

AL XIV-LEA CONGRES

AL SOCIETĂŢII DE NEUROLOGIE DIN ROMÂNIA

- Primul anunţ -

BUCUREŞTI, 18-21 MAI 2016

www. neurology.ro

Mai multe detalii aici

ECTRIMS FELLOWSHIP PROGRAMMES 2016

 

ECTRIMS FELLOWSHIP PROGRAMMES 2016

*** ECTRIMS Fellowship Competition 2016 has started ***
*** Online application now open ***

ECTRIMS Postdoctoral Research Fellowship Exchange Programme
ECTRIMS Multiple Sclerosis Clinical Training Fellowship Programme
ECTRIMS Multiple Sclerosis Nurse Training Fellowship Programme
ECTRIMS-MAGNIMS Fellowship in Magnetic Resonance Imagining in MS

********************************************************************

ECTRIMS Postdoctoral Research Fellowship Exchange Programme

and

ECTRIMS Multiple Sclerosis Clinical Training Fellowship Programme

Application Deadline: 1 December 2015

********************************************************************

ECTRIMS Postdoctoral Research Fellowship Exchange Programme

This fellowship is offered to young postdoctoral neuroscientists to facilitate their conduct of and training in basic, clinical or applied research related to MS in European laboratories or clinics. The goal is to maximize exchange of information and help grow the pool of well-trained scientists focused on MS.
ECTRIMS will support up to three fellowships annually, each with duration of 1 or 2 years, with an annual stipend of €50,000. Fellows are expected to identify a European research training environment and mentor prior to application and to devote full-time to research and training during their fellowship period (up to 10% time and effort can be spent on teaching and/or clinical care).
********************************************************************

ECTRIMS Multiple Sclerosis Clinical Training Fellowship Programme

This fellowship is offered to neurologists and other physicians to provide the opportunity to learn the latest techniques in patient management and care and to help foster their careers as MS physicians. It is available for 3, 6 or 12 months and must be performed under the direction of a senior clinical mentor at a European MS clinic and/or MS research center. Fellows may come from any location but priority will be given to candidates from developing countries.
ECTRIMS will award up to three fellowships annually, with a stipend of up to €50,000. The programme is intended to be a full-time MS clinical care training experience. This can include 'hands on' clinical care under the guidance of the mentor, correlated course work in the training institutions, and may also include time involved in clinical research under the guidance of the mentor.
********************************************************************

ECTRIMS Multiple Sclerosis Nurse Training Fellowship Programme

and

ECTRIMS-MAGNIMS Fellowship in Magnetic Resonance Imagining in MS

Application Deadline: 1 February 2016

********************************************************************

ECTRIMS Multiple Sclerosis Nurse Training Fellowship Programme

This fellowship is offered to qualified/licensed European nurses to provide the opportunity for them to obtain additional expertise through practical nursing experience and training in a mentored MS environment in Europe. The aim of the programme is to enhance care and support of individuals with MS by fostering improved clinical care and education and by helping to promote best practices in nursing care throughout Europe.
ECTRIMS will support up to three fellowships each year, each with duration of 6 months to 1 year, with a stipend of up to €50,000. Training must be under the direction and mentorship of a senior MS nurse, in association with a senior MS clinician where appropriate, at a European clinical site with significant expertise in MS.
********************************************************************

ECTRIMS-MAGNIMS Fellowship in Magnetic Resonance Imagining in MS

ECTRIMS and the European MAGNIMS (Magnetic Resonance in MS) network jointly support a postdoctoral fellowship to foster the development of young researchers in magnetic resonance studies in MS. The goal of this programme is to achieve transfer and broadening of knowledge regarding the application of magnetic resonance to MS research and to promote the researcher’s integration into the international scientific community.
ECTRIMS will support two fellowships annually, each with duration of 1 year, with an annual stipend of up to €50,000.
********************************************************************
Details about all ECTRIMS Fellowship Programmes and application material can be obtained from the ECTRIMS website: www.ectrims.eu/fellowships

 

A apărut revizuirea ghidului AHA/ ASA privind tratamentul endovascular in acut al AVC ischemic

Mai multe detalii accesand linkul

AHA/ASA Guideline

2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment

A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

William J. Powers, MD, FAHA, Chair, Colin P. Derdeyn, MD, FAHA, Vice Chair, José Biller, MD, FAHA, Christopher S. Coffey, PhD, Brian L. Hoh, MD, FAHA, Edward C. Jauch, MD, MS, FAHA, Karen C. Johnston, MD, MSc, S. Claiborne Johnston, MD, PhD, FAHA, Alexander A. Khalessi, MD, MS, FAHA, Chelsea S. Kidwell, MD, FAHA, James F. Meschia, MD, FAHA, Bruce Ovbiagele, MD, MSc, MAS, FAHA and Dileep R. Yavagal, MD, MBBS; on behalf of the American Heart Association Stroke Council

Abstract

Purpose—The aim of this guideline is to provide a focused update of the current recommendations for the endovascular treatment of acute ischemic stroke. Where there is overlap, the recommendations made here supersede those of previous guidelines.

Methods—This focused update analyzes results from 8 randomized clinical trials of endovascular treatment and other relevant data published since 2013. It is not intended to be a complete literature review from the date of the previous guideline publication but rather to include pivotal new evidence that justifies changes in current recommendations. Members of the writing committee were appointed by the American Heart Association/American Stroke Association Stroke Council’s Scientific Statement Oversight Committee and the American Heart Association/American Stroke Association Manuscript Oversight Committee (MOC). Strict adherence to the American Heart Association conflict of interest policy was maintained throughout the consensus process. Recommendations follow the American Heart Association/American Stroke Association methods of classifying the level of certainty of the treatment effect and the class of evidence. Prerelease review of the draft guideline was performed by 6 expert peer reviewers and by the members of the Stroke Council Scientific Statement Oversight Committee and Stroke Council Leadership Committee.

Results—Evidence-based guidelines are presented for the selection of patients with acute ischemic stroke for endovascular treatment, the endovascular procedure and for systems of care to facilitate endovascular treatment.

Conclusions—Certain endovascular procedures have been demonstrated to provide clinical benefit in selected patients with acute ischemic stroke. Systems of care should be organized to facilitate the delivery of this care.

KIND REMINDER: Announcing the up-coming 9th Congress on Vascular Dementia (ICVD 2015), Ljubljana, Slovenia, October 16-18, 2015 (2)

It is our pleasure to introduce the 9th International Congress on Vascular Dementia – ICVD 2015, which will be held in Ljubljana, Slovenia, 16-18 October, 2015.

ICVD 2015 will be a showcase for the discussion of new developments in the area of dementia with special attention to cerebrovascular diseases affecting cognition and behavior. The congress will be an opportunity to deliberate on large and small vessel brain diseases and how they affect the mind.

We shall try to identify specific biological and psychological markers of vascular cognitive impairment, and also the genetic factors involved.

Please find here below the link to the Congress website
http://www.comtecmed.com/icvd